Investee Company Update: Little Green Pharma Ltd

SEED Innovations Ltd, the AIM-quoted investment company offering exposure to disruptive, high-growth, life sciences and technology ventures typically inaccessible to everyday investors, is pleased to note that its portfolio company, Little Green Pharma Ltd ("LGP"), has published its quarterly activities report and Appendix 4C for the period ending 30 June 2025 on the ASX.

SEED holds 7,324,796 ordinary shares in LGP, representing approximately 2.4% of LGP's issued share capital.

Commenting on the announcement, Alfredo Pascual, Executive Director at SEED said:

LGP has delivered another compelling quarter, achieving record cash receipts of A$12.0 million and a turnaround to a positive net operating cash inflow of A$0.5 million. This positive cash flow trend, combined with cash in bank of A$2.5 million and over A$5.0 million in unused financing facilities, enhances LGP's financial flexibility. We are particularly encouraged by the over 70% increase in Danish facility sales into Germany and over A$2.0 million in new UK purchase orders for FY26Q2 and Q3, which reinforce our confidence in LGP's strategic focus and growth trajectory in key international markets."

Little Green Pharma Ltd

Quarterly Activities Report and Appendix 4C

Little Green Pharma Ltd (ASX: LGP, "LGP" or the "Company") is pleased to provide its activities report and Appendix 4C for the quarter ending 30 June 2025.

Highlights

• Operating cashflow of $0.5 million resulting in an increase in total cash of $0.15 million
• Revenue of $9.1 million (unaudited) up over 20% on prior corresponding period and cash receipts of $12.0 million up nearly 50% on prior corresponding period
• 31 March 2025 full year financial statements completed with a clean audit opinion; Revenue of $36.8 million (52% CAGR between FY22-FY25); Adjusted EBITDA of $2.9 million; Net Profit after Tax of $3.3 million and Net Tangible Assets of $0.24 per share
• Danish facility sales into Germany up over 70% as German market registers record imports of 37.2 tonnes
• First LGP branded products launched in Germany under CherryCo line New 2.4tpa room at Danish Facility commissioned giving a total capacity of 8.5tpa with another 2.4tpa room currently being fitted out
• New laws facilitating Danish site to act as cannabis import, packing and distribution hub effective 1 January 2026 with preparations underway
• Cash in bank of $2.5 million, up from $2.4 million in prior quarter with over $5.0 million in unused financing facilities

The announcement in full can be accessed via the following link: https://investlittlegreenpharma.com/site/investor-centre/asx-announcements

Nominated Adviser Statement